Health
Researchers examine unanticipated benefits of GLP-1 medications - Medical Xpress

What the report says
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and Dr. Adam Gilden of the University of …
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Health Ministry Launches m-PIMA Technology to Expand HIV Testing in Rural AreasNile Post
Akech Warns Health Workers Against Absenteeism as Tetugo HCIII Gets Staff HousesDokolo Post
Rabies cases increased 17 percent in July and August, CDC says - The Washington PostThe Washington Post